Revolutionizing Antibody Design with AI: Why We’re Backing Chai Discovery | Menlo Ventures
Chai Discovery is building foundation models for biology and drug discovery to transform how biopharma creates new therapies.| Menlo Ventures
Chai Discovery is building foundation models for biology and drug discovery to transform how biopharma creates new therapies.| Menlo Ventures
We are thrilled to announce our investment in OpenRouter: one API, centralized billing, and access to 400+ AI models across 60+ providers.| Menlo Ventures
Wispr is developing a foundational voice layer for technology—a fluid, intelligent, and genuinely intuitive interface for all humans.| Menlo Ventures
Anthropic is an AI safety and research company that builds reliable, interpretable, and steerable AI systems.| Menlo Ventures
The Anthology Fund is a $100 million initiative between Menlo Ventures and Anthropic to fund world-changing AI companies.| Menlo Ventures
